Sharecafe

AdAlta (ASX:1AD) – Webinar Presentation

Tim Oldham - CEO & Managing Director - AdAlta Limited (ASX:1AD) is a clinical-stage biotechnology company. The company’s lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis.

 

Tim Oldham – CEO & Managing Director – AdAlta Limited (ASX:1AD) is a clinical-stage biotechnology company. The company’s lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories